Radiation-Induced Alterations in Cancer-Associated Fibroblasts: Drivers of Tumor Radioresistance and Therapeutic Targets
Biomolecules · 26.05.2026 · 16 (6) · 777
DOI: 10.3390/biom16060777 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 26.05.2026. Verfasst von Zheng Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Biopharmaceutical and Engineering, Lanzhou Jiaotong University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Radiation Tolerance, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Innovation Talent Program of Chengguan District, Top Talents Project of Gansu Province.
Abstract (Originalsprache)
Radiotherapy serves as a cornerstone of cancer treatment, but its efficacy is often compromised by radioresistance, a process in which cancer-associated fibroblasts (CAFs) play a critical role. Following irradiation, CAFs exhibit inherent radioresistance, not only surviving at higher doses but also undergoing profound functional reprogramming, including senescence, acquisition of a senescence-associated secretory phenotype (SASP), and myofibroblast activation. Importantly, CAFs employ multiple interconnected mechanisms to collectively drive radioresistance: sustained immunosuppression, pro-resistance paracrine signaling, exosome-mediated communication, and stromal remodeling. These reprogrammed CAFs create a microenvironment that paradoxically supports tumor recurrence and limits therapeutic efficacy. Intervention strategies targeting CAFs—including neutralizing soluble factors, blocking key signaling nodes, targeted therapies against fibroblast activation proteins, or disrupting exosome-mediated communication—have shown promise in preclinical studies. A deeper understanding of the complex interactions between radiotherapy and CAFs may ultimately drive a shift in therapeutic strategy from targeting tumor cells alone to leveraging the entire microenvironment to achieve durable antitumor effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Biopharmaceutical and Engineering, Lanzhou Jiaotong University, Lanzhou 730000, China.
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
- Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Sciences, Lanzhou 730000, China.
ORCID-Profile: Chao Sun
Förderung
- Science and Technology Innovation Talent Program of Chengguan District
- Top Talents Project of Gansu Province
Zitieren
APA
Shi, Z., Hu, C., & Sun, C. (2026). Radiation-Induced Alterations in Cancer-Associated Fibroblasts: Drivers of Tumor Radioresistance and Therapeutic Targets. Biomolecules, 16(6), 777. https://doi.org/10.3390/biom16060777
Vancouver
Shi Z, Hu C, Sun C. Radiation-Induced Alterations in Cancer-Associated Fibroblasts: Drivers of Tumor Radioresistance and Therapeutic Targets. Biomolecules. 2026;16(6):777. doi:10.3390/biom16060777
BibTeX
@article{Shi2026,
author = {Shi, Zheng and Hu, Cuilan and Sun, Chao},
title = {Radiation-Induced Alterations in Cancer-Associated Fibroblasts: Drivers of Tumor Radioresistance and Therapeutic Targets},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {6},
pages = {777},
doi = {10.3390/biom16060777}
}
EUVIMED